SCHEMBL2256052

SCHEMBL2256052

O=C(O)c1ccc(-c2ccc(F)cc2)cc1C=CCc1ccc2cccc(O)c2c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ BCL2L1 Q07817 1/20 0.51
▸ BAD Q92934 1/20 0.51
▸ GRIN2D O15399 1/20 0.39
▸ GRIN2A Q12879 1/20 0.39
▸ GRIN2B Q13224 1/20 0.39
▸ GRIN2C Q14957 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ STING1 Q86WV6 1/20 0.39
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ DHODH Q02127 2/20 0.35
▸ ACMSD Q8TDX5 5/20 0.35
▸ HNF4A P41235 1/20 0.35
▸ MCL1 Q07820 2/20 0.35
▸ CYP1B1 Q16678 2/20 0.35
▸ DCLRE1B Q9H816 1/20 0.34
▸ HCAR2 Q8TDS4 2/20 0.34
▸ MRGPRX4 Q96LA9 1/20 0.33
▸ CYP1A1 P04798 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2256047 1.00 BCL2L1 (0.51) BCL2L1BADGRIN2DGRIN2AGRIN2B
SCHEMBL2255104 0.83 BCL2L1 (0.67) BCL2L1BADGRIN2DGRIN2AGRIN2B
SCHEMBL2254597 0.83 BCL2L1 (0.49) BCL2L1BADPPARASTING1HCAR2
SCHEMBL2255098 0.83 BCL2L1 (0.67) BCL2L1BADGRIN2DGRIN2AGRIN2B
SCHEMBL2254605 0.83 BCL2L1 (0.49) BCL2L1BADPPARASTING1HCAR2
SCHEMBL2252475 0.82 BCL2L1 (0.51) BCL2L1BADMEN1KMT2ADHODH
SCHEMBL2252467 0.82 BCL2L1 (0.51) BCL2L1BADMEN1KMT2ADHODH
SCHEMBL2257615 0.79 SOX18 (0.46) BCL2L1BADGRIN2DGRIN2AGRIN2B
SCHEMBL2253800 0.77 ACLY (0.50) BCL2L1BADGRIN2DGRIN2AGRIN2B
SCHEMBL2254380 0.77 DCLRE1B (0.43) BCL2L1BADGRIN2DGRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904047-B1 APOPTOSIS PROMOTERS ABBOTT LAB (US) 2013-01-02 — — EP disclosed
US-7989656-B2 Biaryl carboxylic acid apoptosis promoters ABBOTT LABORATORIES (US) 2011-08-02 — — US disclosed
US-20100234456-A1 APOPTOSIS PROMOTERS ABBOTT LABORATORIES (US) 2010-09-16 — — US disclosed
US-7750004-B2 Apoptosis promoters ABBOTT LABORATORIES (US) 2010-07-06 — — US disclosed
US-20070135392-A1 Apoptosis promoters ABBVIE INC. 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234456-A1 APOPTOSIS PROMOTERS MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885GRIN2D 4683/4885
US-20070135392-A1 Apoptosis promoters MCL1, BAX, BCL2 BCL2L1 5/4885BAD 11/4885GRIN2D 4683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback